1. Kutsuna S, Asai Y, Matsunaga A. “Loss of anti-SARS-CoV-2 antibodies in mild COVID-19” N. Eng. J. Med., (2020); 383(17):1695-1696, doi:10.1056/NEJMc2027051
2. Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terda M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Maeda K, Takasaki J, Hojo M, Ishizaka Y, Norio Ohmagari N. Factors associated with antiSARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J. Infect. Chemotherapy. (2021); 27(6):808-813, doi:10.1016/j.jiac.2021.01.006
3. Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep. (2021);11(1):5563. doi: 10.1038/s41598-021-84733-5
4. Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, Kenta Tezuka, Emi Ikebe, Sho Saito, Noriko Kinoshita, Mari Terada, Mio Endo, Tetsuya Suzuki, Yusuke Miyazato, Takato Nakamoto, Makoto Inada, Isao Hamaguchi, Norio Ohmagari. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J. Infect. Chemotherapy. (2021); 27(4):653-655. Doi:10.1016/j/jiac.2021.01.004
5. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Konishita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J. Infect. Chemotherapy. (2021) In press. doi:10.1016/j/jic.2021.04.017
6. Yamayoshi S, Yasuhara A, Ito M, Akasaka O, Nakamura M, Nakachi I, Koga M, Mitamura K, Yagi K, Maeda K, Kato H, Nojima M, Pattinson D, Ogura T, Baba R, Fujita K, Nagai H, Yamamoto S, Saito M, Adachi E, Ochi J, Hattori SI, Suzuki T, Miyazato Y, Chiba S, Okuda M, Murakami J, Hamabata T, Iwatsuki-Horimoto K, Nakajima H, Mitsuya H, Omagari N, Sugaya N, Yotsuyanagi H, Kawaoka Y. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. EClinialMedicine, (2021):100734. doi: 10.1016/j.eclinm.2021.100734
7. Noda K, Matsuda K, Yagishita S, Maeda K, Akiyama Y, Terada-Hirashima J, Matsushita H, Iwata S, Yamashita K, Atarashi Y, Watanabe S, Ide N, Yoshida T, Ohmagari N, Mitsuya M, Hamada A. A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies. Sci. Rep. (2021);11(1):5198. doi: 10.1038/s41598-021-84387-3